253 related articles for article (PubMed ID: 11801488)
21. Rituximab in combination with interferon-alpha in relapsed and refractory diffuse large B-cell non-Hodgkin's lymphoma.
Bertè R; Vallisa D; Civardi G; Moroni CF; Lazzaro A; Cavanna L
Acta Haematol; 2001; 106(3):141-2. PubMed ID: 11713384
[No Abstract] [Full Text] [Related]
22. [Recent advances and the treatment strategies of AIDS-related malignant lymphoma].
Okada S
Rinsho Ketsueki; 2008 Oct; 49(10):1490-8. PubMed ID: 18833933
[No Abstract] [Full Text] [Related]
23. Phase I/II study of the rituximab-EPOCT regimen in combination with granulocyte colony-stimulating factor in patients with relapsed or refractory follicular lymphoma including evaluation of its cardiotoxicity using B-type natriuretic peptide and troponin T levels.
Niitsu N; Khori M; Hayama M; Kajiwara K; Higashihara M; Tamaru J
Clin Cancer Res; 2005 Jan; 11(2 Pt 1):697-702. PubMed ID: 15701858
[TBL] [Abstract][Full Text] [Related]
24. Rituximab combined with autologous peripheral blood stem cell transplantation improve therapeutic effects of chemotherapy in pediatric patients with Burkitt's lymphoma.
Li Y; Huang S; Wang X; Zhou D; Huang K; Guo H; Fang J; Chen C; Liu Q
J Trop Pediatr; 2010 Oct; 56(5):337-41. PubMed ID: 20065046
[TBL] [Abstract][Full Text] [Related]
25. Safety and feasibility of CHOP/rituximab induction treatment followed by high-dose chemo/radiotherapy and autologous PBSC-transplantation in patients with previously untreated mantle cell or indolent B-cell-non-Hodgkin's lymphoma.
Hess G; Flohr T; Huber C; Kolbe K; Derigs HG; Fischer T
Bone Marrow Transplant; 2003 May; 31(9):775-82. PubMed ID: 12732884
[TBL] [Abstract][Full Text] [Related]
26. The therapeutic use of rituximab in non-Hodgkin's lymphoma.
Marcus R; Hagenbeek A
Eur J Haematol Suppl; 2007 Jan; (67):5-14. PubMed ID: 17206982
[TBL] [Abstract][Full Text] [Related]
27. A phase II trial of rituximab as adjuvant to intensive sequential chemotherapy in patients under 60 years with untreated poor-prognosis diffuse large B-cell lymphoma.
Coso D; Sebban C; Boulat O; Biron P; Rey J; Aurran T; Chabannon C; Xerri L; Chetaille B; Esterni B; Ivanov V; Stoppa AM; Schiano de Collela JM; Gastaut JA; Maraninchi D; Bouabdallah R
Bone Marrow Transplant; 2006 Aug; 38(3):217-22. PubMed ID: 16770316
[TBL] [Abstract][Full Text] [Related]
28. Ophthalmologic outcomes after chemotherapy and/or radiotherapy in non-conjunctival ocular adnexal MALT lymphoma.
Paik JS; Cho WK; Lee SE; Choi BO; Jung SE; Park GS; Kim SH; Yang SW; Cho SG
Ann Hematol; 2012 Sep; 91(9):1393-401. PubMed ID: 22543827
[TBL] [Abstract][Full Text] [Related]
29. [Efficacy of modified B-NHL-BFM-90 protocol on Burkitt's lymphoma in Chinese children and adolescents].
Sun XF; Zhen ZJ; Liu DG; Xia Y; Xiang XJ; Chen XQ; Ling JY; Zheng L; Luo WB; Lin H; He YJ; Guan ZZ
Ai Zheng; 2007 Dec; 26(12):1339-43. PubMed ID: 18076797
[TBL] [Abstract][Full Text] [Related]
30. [Efficacy of rituximab-containing salvage regimens on relapsed or refractory B-cell non-Hodgkin's lymphoma].
Huang HQ; Bu Q; Xia ZJ; Lin XB; Wang FH; Li YH; Peng YL; Pan ZH; Wang SS; Lin TY; Jiang WQ; Guan ZZ
Ai Zheng; 2006 Apr; 25(4):486-9. PubMed ID: 16613686
[TBL] [Abstract][Full Text] [Related]
31. Chimeric anti-CD20 monoclonal antibody (Mabthera) in remission induction and maintenance treatment of relapsed follicular non-Hodgkin's lymphoma: a phase III randomized clinical trial--Intergroup Collaborative Study.
Van Oers MH; Hagenbeek A; Van Glabbeke M; Teodorovic I
Ann Hematol; 2002 Oct; 81(10):553-7. PubMed ID: 12424535
[No Abstract] [Full Text] [Related]
32. Results of treatment of 112 cases of primary CNS lymphoma.
Yamanaka R; Morii K; Shinbo Y; Homma J; Sano M; Tsuchiya N; Yajima N; Tamura T; Hondoh H; Takahashi H; Kakuma T; Tanaka R
Jpn J Clin Oncol; 2008 May; 38(5):373-80. PubMed ID: 18413337
[TBL] [Abstract][Full Text] [Related]
33. Successful treatment with modified CHOP-rituximab in pediatric AIDS-related advanced stage Burkitt lymphoma.
Crosswell HE; Bergsagel DJ; Yost R; Lew G
Pediatr Blood Cancer; 2008 Apr; 50(4):883-5. PubMed ID: 17278123
[TBL] [Abstract][Full Text] [Related]
34. Non-Hodgkin's lymphoma (diffuse large B cell lymphoma).
Copson E
Clin Evid; 2005 Jun; (13):1-18. PubMed ID: 16135258
[No Abstract] [Full Text] [Related]
35. Burkitt lymphomas failing dose-adjusted R-EPOCH (DA-R-EPOCH).
Aurer I; Bašić-Kinda S; Radman I; Ilić I; Grah JJ
Ann Hematol; 2014 Jan; 93(1):177-8. PubMed ID: 23636314
[No Abstract] [Full Text] [Related]
36. Developing new monoclonal antibodies for aggressive lymphoma: a challenging road in the rituximab era.
Friedberg JW
Clin Cancer Res; 2004 Aug; 10(16):5297-8. PubMed ID: 15328164
[No Abstract] [Full Text] [Related]
37. [Acute kidney failure as the clinical presenting form of renal Burkitt's lymphoma in an HIV-positive patient].
Saurina A; Ramírez de Arellano M; Chiné M; Fulquet M; Lladó I; de las Cuevas X
Nefrologia; 2001; 21(6):601-5. PubMed ID: 11881432
[TBL] [Abstract][Full Text] [Related]
38. Remission of severe antiphospholipid syndrome associated with non-Hodgkin's B-cell lymphoma after combined treatment with rituximab and chemotherapy.
Veneri D; Ambrosetti A; Franchini M; Mosna F; Poli G; Pizzolo G
Haematologica; 2005 Nov; 90 Suppl():ECR37. PubMed ID: 16266928
[TBL] [Abstract][Full Text] [Related]
39. Chronic myeloid leukemia following cyclophosphamide-containing chemotherapy in a breast cancer patient.
Porta C; Casagranda I; Semino G; Moroni M; Ratto C
Haematologica; 1993; 78(1):56-7. PubMed ID: 8387943
[No Abstract] [Full Text] [Related]
40. A high tumor-associated macrophage content predicts favorable outcome in follicular lymphoma patients treated with rituximab and cyclophosphamide-doxorubicin-vincristine-prednisone.
Taskinen M; Karjalainen-Lindsberg ML; Nyman H; Eerola LM; Leppä S
Clin Cancer Res; 2007 Oct; 13(19):5784-9. PubMed ID: 17908969
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]